Why college cuts your risk of heart disease quoting : Daily Mail Online

Dr Kubota and colleagues set out to calculate the lifetime risk of CVD - which includes coronary heart disease, heart failure and stroke - according to educational levels to convey it. Going to university slashes the risk of heart disease, particularly among women, new research shows. But Dr Kubota said: 'Even with such a proviso, our estimates of lifetime risk can help in elucidating the association between education and CVD risk.' A 30-year study has shown a clear correlation between education levels and heart disease. He added: 'Educational attainment was inversely associated with the lifetime risk of CVD, regardless of other important socioeconomic characteristics.




The medicine also led to a reduced risk of hospitalization for heart failure and protection against kidney function decline. Johnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart disease or at elevated risk in a pair of large studies, according to data presented at a medical meeting on Monday. But the risk of amputations, particularly of toes or feet, was double versus placebo in the studies of 10,142 patients with type 2 diabetes. This (heart disease) is the main thing that people with diabetes die from," said Neal, who presented the data at the American Diabetes Association meeting in San Diego. On the study's main goal Invokana, known chemically as canagliflozin, reduced the combined risk of heart-related death, nonfatal heart attack and nonfatal stroke by a statistically significant 14 percent compared with placebo.

Anti-diabetes drug also reduces kidney, heart disease risk: study

It found the drug reduced the overall risk of cardiovascular disease by 14% and reduced the risk of heart failure hospitalization by 33%. Now, a study has found that an anti-diabetic drug that lowers blood sugar levels for type 2 diabetes sufferers also significantly cuts the risk of cardiovascular and kidney disease, according to a study. Our findings suggest not only does canagliflozin significantly reduce the risk of heart disease, it also has many other benefits too," said the group's Bruce Neal. "Coronary heart disease is the biggest killer by far for people with type 2 diabetes. This results in more glucose being released in urine and a drop in glucose levels.


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases